A novel anti-rheumatic drug suppresses tumor necrosis factor-α and augments interleukin-10 in adjuvant arthritic rats

被引：23

作者：

Hisadome, M ^{[1
]}

Fukuda, T ^{[1
]}

Sumichika, H ^{[1
]}

Hanano, T ^{[1
]}

Adachi, K ^{[1
]}

机构：

[1] Welfide Corp, Res Labs, Yoshitomi, Fukuoka 8718550, Japan

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2000年 / 409卷 / 03期

关键词：

Y-39041; arthritis; TNF-alpha (tumor necrosis factor-alpha); interleukin-10; lipopolysaccharide;

D O I：

10.1016/S0014-2999(00)00866-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Tumor necrosis factor-alpha (TNF-alpha) plays an important role in the pathology of rheumatoid arthritis. When N-[1-(4-([4-(pyrimidin-2-yl)piperazin-1-yl]methyl)phenyl)cyclopropyl]acetamide (Y-39041) (3-30 mg/kg) was orally administered to rats with established arthritis from day 15 to day 20, hindpaw volume was significantly reduced. This inhibitory activity of Y-39041 was kept up after administration was stopped. On day 17 Y-39041 suppressed lipopolysaccharide-induced TNF-alpha and interleukin-6 production in serum at doses of 3-30 mg/kg, and augmented interleukin-10 production at doses of 10 and 30 mg/kg. The finding that Y-39041 suppresses TNF-alpha and interleukin-6 production and augments interleukin-10 production could be beneficial in the therapy of chronic inflammatory diseases. (C) 2000 Elsevier Science B.V. All rights reserved.

引用

页码：331 / 335

页数：5

共 50 条

[31] LIPOPOLYSACCHARIDE-INDUCED INTERLEUKIN-10 IN MICE - ROLE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR-ALPHA [J].

BARSIG, J ;

KUSTERS, S ;

VOGT, K ;

VOLK, HD ;

TIEGS, G ;

WENDEL, A .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) :2888-2893

[32] Tumour necrosis factor-α/interleukin-10 ratio in patients with obstructive sleep apnoea hypopnoea syndrome [J].

Jiang, H. ;

Cao, H. ;

Wang, P. ;

Liu, W. ;

Cao, F. ;

Chen, J. .

JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (01) :73-78

[33] Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression [J].

Meisel, C ;

Vogt, K ;

Platzer, C ;

Randow, D ;

Liebenthal, C ;

Volk, HD .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1580-1586

[34] Protective effects of heme-oxygenase expression against endotoxic shock:: Inhibition of tumor necrosis factor-α and augmentation of interleukin-10 [J].

Tamion, Fabienne ;

Richard, Vincent ;

Renet, Sylvanie ;

Thuillez, Christian .

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2006, 61 (05) :1078-1084

[35] Toll-like receptors, tumor necrosis factor-α, and interleukin-10 gene polymorphisms in risk of pulmonary tuberculosis and disease severity [J].

Ma, Mai-juan ;

Xie, Lan-pin ;

Wu, Shu-cai ;

Tang, Fang ;

Li, Hao ;

Zhang, Zheng-shan ;

Yang, Hong ;

Chen, Su-li ;

Liu, Ning ;

Liu, Wei ;

Cao, Wu-chun .

HUMAN IMMUNOLOGY, 2010, 71 (10) :1005-1010

[36] The balance between the production of tumor necrosis factor-α and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion [J].

Souza, DG ;

Teixeira, MM .

MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2005, 100 :59-66

[37] Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-α and nitric oxide production in vivo and in vitro [J].

Haskó, G ;

Szabó, C ;

Németh, ZH ;

Lendvai, B ;

Vizi, ES .

BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (06) :1099-1106

[38] Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naiive and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases [J].

Takahashi, Naomi ;

Noda, Shinji ;

Taniguchi, Takashi ;

Adachi, Makoto .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (10) :1194-1198

[39] Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents [J].

Siegmund, B ;

Eigler, A ;

Moeller, J ;

Greten, TF ;

Hartmann, G ;

Endres, S .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (02) :231-239

[40] Down-regulation of tumor necrosis factor-α, moderate reduction of interleukin-1β, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan [J].

Masihi, KN ;

Madaj, K ;

Hintelmann, H ;

Gast, G ;

Kaneko, Y .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1997, 19 (9-10) :463-468

← 1 2 3 4 5 →